Related Experiment Video
Updated: Jun 5, 2026

In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
Modulation of signaling between TM4SF5 and integrins in tumor microenvironment
Sin-Ae Lee1, Ki Hun Park, Jung Weon Lee
1Department of Pharmacy, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 151-742, Korea.
Abstract:
TM4SF5 is a transmembrane glycoprotein of the transmembrane 4 L six family, a branch of the tetraspanin family and highly expressed in many types of cancers. TM4SF5 induces epithelial-mesenchymal transition (EMT) by morphological changes resulting from inactivation of RhoA mediated by stabilized cytosolic p27kip1. TM4SF5-mediated EMT can lead to loss of contact inhibition and enhanced migration/invasion, presumably depending on cross-talks between TM4SF5 and integrins. An anti-TM4SF5 agent appears to target the second extracellular domain of TM4SF5, which is important for cross-talk with integrins, leading to a blockade of TM4SF5-mediated multilayer growth and migration/invasion. In addition, TM4SF5 engages in cross-talk with integrin alpha5 to induce and secrete VEGF, which in turn causes activation of angiogenesis in endothelial cells. Therefore, TM4SF5 plays a central regulatory role in a wide variety of physiological processes through cross-talk with integrins. This review presents current knowledge from in vitro and in vivo observations of the roles of TM4SF5-integrin cooperation in hepatocellular carcinogenesis and discusses important areas for future investigation.
Insights
Transmembrane protein 4 family member 5 (TM4SF5) drives cancer progression by promoting epithelial-mesenchymal transition (EMT) and angiogenesis. Targeting TM4SF5 interactions with integrins inhibits cancer growth and spread.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Transmembrane protein 4 family member 5 (TM4SF5) is highly expressed in various cancers.
- TM4SF5 is a member of the tetraspanin superfamily, involved in cell signaling.
- TM4SF5 plays a role in cancer progression through epithelial-mesenchymal transition (EMT).
Purpose of the Study:
- To review the role of TM4SF5-integrin cooperation in hepatocellular carcinogenesis.
- To discuss the mechanisms by which TM4SF5 influences cancer progression.
- To highlight potential therapeutic strategies targeting TM4SF5.
Main Methods:
- Review of in vitro and in vivo studies.
- Analysis of TM4SF5 interactions with integrins.
- Examination of TM4SF5-mediated signaling pathways.
Main Results:
- TM4SF5 induces EMT via RhoA inactivation and p27kip1 stabilization.
- TM4SF5-integrin crosstalk promotes cell migration, invasion, and loss of contact inhibition.
- TM4SF5-integrin alpha5 interaction stimulates VEGF secretion and angiogenesis.
Conclusions:
- TM4SF5 is a key regulator of cancer progression through integrin interactions.
- Targeting the TM4SF5 extracellular domain can block cancer growth and metastasis.
- TM4SF5-integrin cooperation is crucial in hepatocellular carcinogenesis, warranting further investigation.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
TGF - β Signaling Pathway

